DK1087986T3 - Testosteronderivat - Google Patents

Testosteronderivat

Info

Publication number
DK1087986T3
DK1087986T3 DK99929208T DK99929208T DK1087986T3 DK 1087986 T3 DK1087986 T3 DK 1087986T3 DK 99929208 T DK99929208 T DK 99929208T DK 99929208 T DK99929208 T DK 99929208T DK 1087986 T3 DK1087986 T3 DK 1087986T3
Authority
DK
Denmark
Prior art keywords
testosterone
compound
testosterone derivative
good
oxoundecyl
Prior art date
Application number
DK99929208T
Other languages
Danish (da)
English (en)
Inventor
Dirk Leysen
Der Voort Hendrikus Adrian Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1087986T3 publication Critical patent/DK1087986T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicinal Preparation (AREA)
DK99929208T 1998-06-19 1999-06-14 Testosteronderivat DK1087986T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202052 1998-06-19
PCT/EP1999/004102 WO1999067271A1 (en) 1998-06-19 1999-06-14 Testosterone derivative

Publications (1)

Publication Number Publication Date
DK1087986T3 true DK1087986T3 (da) 2002-06-17

Family

ID=8233831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99929208T DK1087986T3 (da) 1998-06-19 1999-06-14 Testosteronderivat

Country Status (26)

Country Link
US (3) US6437158B1 (hu)
EP (1) EP1087986B1 (hu)
JP (1) JP2002518514A (hu)
KR (1) KR100596649B1 (hu)
CN (1) CN1172949C (hu)
AT (1) ATE215961T1 (hu)
AU (1) AU756739B2 (hu)
BR (1) BR9911344A (hu)
CA (1) CA2333985C (hu)
CZ (1) CZ293319B6 (hu)
DE (1) DE69901250T2 (hu)
DK (1) DK1087986T3 (hu)
ES (1) ES2175989T3 (hu)
HK (1) HK1034263A1 (hu)
HU (1) HUP0102274A3 (hu)
ID (1) ID27260A (hu)
IL (1) IL139689A (hu)
NO (1) NO316518B1 (hu)
NZ (1) NZ508299A (hu)
PL (1) PL191285B1 (hu)
PT (1) PT1087986E (hu)
RU (1) RU2216546C2 (hu)
SK (1) SK282796B6 (hu)
TR (1) TR200003743T2 (hu)
WO (1) WO1999067271A1 (hu)
ZA (1) ZA200006813B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
AU8201601A (en) * 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
JP3774888B2 (ja) * 2001-11-28 2006-05-17 日本化薬株式会社 ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
TW200403065A (en) 2002-05-30 2004-03-01 Akzo Nobel Nv New etonogestrel esters
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP1879382B1 (en) 2006-07-10 2017-09-06 Samsung Electronics Co., Ltd. Multi-screen display apparatus and method for digital broadcast receiver
WO2008101030A1 (en) * 2007-02-13 2008-08-21 The Regents Of The University Of California Methods for amplifying steroid hormone effects
US20090017107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase libido
US20090018107A1 (en) * 2007-07-13 2009-01-15 Oral Delivery Technology Ltd. Novel composition to increase muscle strength
US20100303937A1 (en) * 2009-06-01 2010-12-02 Michael Farber Novel composition to increase testosterone levels
CN102558267A (zh) * 2012-01-13 2012-07-11 宜城市共同药业有限公司 庚酸睾酮的制备方法
US9950125B2 (en) * 2012-04-06 2018-04-24 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
PT2953667T (pt) 2013-02-11 2020-01-28 Antares Pharma Inc Dispositivo de injeção a jato auxiliado por agulha tendo força de gatilho reduzida

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation

Also Published As

Publication number Publication date
KR100596649B1 (ko) 2006-07-06
EP1087986A1 (en) 2001-04-04
BR9911344A (pt) 2001-03-13
SK19402000A3 (sk) 2001-07-10
AU756739B2 (en) 2003-01-23
CA2333985C (en) 2007-04-10
IL139689A0 (en) 2002-02-10
DE69901250D1 (de) 2002-05-16
ES2175989T3 (es) 2002-11-16
HK1034263A1 (en) 2001-10-19
HUP0102274A2 (hu) 2001-12-28
ID27260A (id) 2001-03-22
CZ20004779A3 (en) 2001-06-13
NO316518B1 (no) 2004-02-02
JP2002518514A (ja) 2002-06-25
AU4610199A (en) 2000-01-10
CZ293319B6 (cs) 2004-04-14
US20050153949A1 (en) 2005-07-14
DE69901250T2 (de) 2002-10-17
US20040033999A1 (en) 2004-02-19
RU2216546C2 (ru) 2003-11-20
ATE215961T1 (de) 2002-04-15
CN1172949C (zh) 2004-10-27
TR200003743T2 (tr) 2001-07-23
NO20006455D0 (no) 2000-12-18
HUP0102274A3 (en) 2002-08-28
US6437158B1 (en) 2002-08-20
CN1305488A (zh) 2001-07-25
IL139689A (en) 2004-09-27
NZ508299A (en) 2003-04-29
PT1087986E (pt) 2002-08-30
US6989378B2 (en) 2006-01-24
ZA200006813B (en) 2002-02-21
WO1999067271A1 (en) 1999-12-29
SK282796B6 (sk) 2002-12-03
KR20010052850A (ko) 2001-06-25
EP1087986B1 (en) 2002-04-10
CA2333985A1 (en) 1999-12-29
PL344987A1 (en) 2001-11-19
PL191285B1 (pl) 2006-04-28
NO20006455L (no) 2000-12-18

Similar Documents

Publication Publication Date Title
DK1087986T3 (da) Testosteronderivat
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
EA200300337A1 (ru) Полиарилкарбоксамиды, применимые в качестве агентов, снижающих содержание липидов
FR2733244B1 (fr) Systeme de stabilisants a base de derives de polyalkylpiperidine
CY1106076T1 (el) Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
AU2610699A (en) Derivatives of glp-1 analogs
MXPA05009985A (es) Ligandos de receptores de canabinoides.
HK1082258A1 (en) Oestrogen derivatives as inhibitors of steroid sulphatase
ES2134847T3 (es) Derivados de taxol.
BR0109703A (pt) Derivados de piperazina
NO20014925L (no) Farmasöytiske forbindelser
ATE278661T1 (de) Anthranilsäurederivate
DE60135748D1 (de) Synthese zyklischerverbindungen
NO20025035D0 (no) Oksadiazolderivater som har anticancer-effekter
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
ATE210642T1 (de) 2-substituierte vitamin-d3-derivate
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
BR0013100A (pt) Processo para a preparação de um composto de 2-arilvinil alquil éter
ECSP992934A (es) Procedimiento mejorado para la preparacion de derivados de norbenzomorfano, valiosos farmaceuticamente
MX9704976A (es) Derivados de 1,2,3-benzotiadiazol.
MY120189A (en) Sultam and sultone derived oxazolidinones